EP1012334A4 - COMPOSITIONS AND METHODS FOR DETERMINING ANTI-VIRAL ACTIVE SUBSTANCE SUSCEPTIBILITY AND RESISTANCE AND ANTI-VIRAL ACTIVE SUBSTANCE SCREENING - Google Patents

COMPOSITIONS AND METHODS FOR DETERMINING ANTI-VIRAL ACTIVE SUBSTANCE SUSCEPTIBILITY AND RESISTANCE AND ANTI-VIRAL ACTIVE SUBSTANCE SCREENING

Info

Publication number
EP1012334A4
EP1012334A4 EP98940779A EP98940779A EP1012334A4 EP 1012334 A4 EP1012334 A4 EP 1012334A4 EP 98940779 A EP98940779 A EP 98940779A EP 98940779 A EP98940779 A EP 98940779A EP 1012334 A4 EP1012334 A4 EP 1012334A4
Authority
EP
European Patent Office
Prior art keywords
active substance
viral active
compositions
resistance
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98940779A
Other languages
German (de)
French (fr)
Other versions
EP1012334A1 (en
Inventor
Daniel J Capon
Jeannette M Whitcomb
Neil T Parkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monogram Biosciences Inc
Original Assignee
Virologic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virologic Inc filed Critical Virologic Inc
Publication of EP1012334A1 publication Critical patent/EP1012334A1/en
Publication of EP1012334A4 publication Critical patent/EP1012334A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP98940779A 1997-07-30 1998-07-30 COMPOSITIONS AND METHODS FOR DETERMINING ANTI-VIRAL ACTIVE SUBSTANCE SUSCEPTIBILITY AND RESISTANCE AND ANTI-VIRAL ACTIVE SUBSTANCE SCREENING Withdrawn EP1012334A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90350797A 1997-07-30 1997-07-30
US903507 1997-07-30
PCT/US1998/015967 WO1999006597A1 (en) 1997-07-30 1998-07-30 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening

Publications (2)

Publication Number Publication Date
EP1012334A1 EP1012334A1 (en) 2000-06-28
EP1012334A4 true EP1012334A4 (en) 2004-12-29

Family

ID=25417619

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98940779A Withdrawn EP1012334A4 (en) 1997-07-30 1998-07-30 COMPOSITIONS AND METHODS FOR DETERMINING ANTI-VIRAL ACTIVE SUBSTANCE SUSCEPTIBILITY AND RESISTANCE AND ANTI-VIRAL ACTIVE SUBSTANCE SCREENING

Country Status (6)

Country Link
EP (1) EP1012334A4 (en)
JP (1) JP2001512036A (en)
KR (1) KR20010022420A (en)
AU (1) AU8897698A (en)
CA (1) CA2298102A1 (en)
WO (1) WO1999006597A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
EP0852626B1 (en) * 1996-01-29 2002-04-03 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US20030028011A1 (en) * 1997-07-30 2003-02-06 Parkin Neil T. Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
AU7268000A (en) * 1999-07-21 2001-02-13 Martin Heinkelein Method for quantization of the antiviral effect of antiviral active principles
EP1352356B1 (en) * 2000-06-08 2009-10-14 Virco Bvba Method for predicting therapeutic agent resistance using neural networks
ES2346717T3 (en) * 2002-03-11 2010-10-19 Lab 21 Limited METHOD AND COMPOSITIONS TO IDENTIFY AND CHARACTERIZE HEPATITIS C.
EP1454988A1 (en) * 2003-03-03 2004-09-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins
EP2527474A1 (en) 2006-10-20 2012-11-28 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS3/4A genomic region
EP2463390A1 (en) 2006-10-20 2012-06-13 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS5B genomic region
WO2013082617A1 (en) * 2011-12-02 2013-06-06 Laboratory Corporation Of America Holdings Methods for the phenotypic detection of hcv inhibitor resistant subpopulations
CN113299340B (en) * 2021-06-09 2023-06-30 四川大学华西医院 Screening method of target test drugs and target test drug screening device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291893A1 (en) * 1987-05-19 1988-11-23 The Du Pont Merck Pharmaceutical Company Stable human cell lines expressing an indicator gene product under virus-specific genetic controls
WO1994008002A2 (en) * 1992-09-28 1994-04-14 Chiron Corporation Methods and compositions for controlling translation of hcv proteins
WO1995022622A1 (en) * 1994-02-18 1995-08-24 University Of Washington Methods and compositions for screening for anti-aids drugs
WO1997027480A1 (en) * 1996-01-26 1997-07-31 Virco N.V. Method of managing the chemotherapy of patients who are hiv positive based on the phenotypic drug sensitivity of human hiv strains
WO1997027319A1 (en) * 1996-01-29 1997-07-31 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291893A1 (en) * 1987-05-19 1988-11-23 The Du Pont Merck Pharmaceutical Company Stable human cell lines expressing an indicator gene product under virus-specific genetic controls
WO1994008002A2 (en) * 1992-09-28 1994-04-14 Chiron Corporation Methods and compositions for controlling translation of hcv proteins
WO1995022622A1 (en) * 1994-02-18 1995-08-24 University Of Washington Methods and compositions for screening for anti-aids drugs
WO1997027480A1 (en) * 1996-01-26 1997-07-31 Virco N.V. Method of managing the chemotherapy of patients who are hiv positive based on the phenotypic drug sensitivity of human hiv strains
WO1997027319A1 (en) * 1996-01-29 1997-07-31 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ENOMOTO N ET AL: "Hepatitis C virus quasispecies populations during chronic hepatitis C infection", TRENDS IN MICROBIOLOGY 1995 UNITED KINGDOM, vol. 3, no. 11, 1995, pages 445 - 447, XP002284841, ISSN: 0966-842X *
HAHM BUMSUK ET AL: "Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity", VIROLOGY, vol. 226, no. 2, 1996, pages 318 - 326, XP002284878, ISSN: 0042-6822 *
See also references of WO9906597A1 *
STRAIR R K ET AL: "RECOMBINANT RETROVIRAL SYSTEMS FOR THE ANALYSIS OF DRUG RESISTANT HIV", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 21, no. 20, 1993, pages 4836 - 4842, XP002924448, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
JP2001512036A (en) 2001-08-21
KR20010022420A (en) 2001-03-15
WO1999006597A1 (en) 1999-02-11
EP1012334A1 (en) 2000-06-28
AU8897698A (en) 1999-02-22
CA2298102A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
ATE447621T1 (en) METHOD FOR DETERMINING ANTIVIRAL ACTIVE SUBSTANCE SUSCEPTIBILITY AND RESISTANCE AND ANTIVIRAL ACTIVE SCREENING
DE69516152D1 (en) COMPOSITIONS AND METHODS OF USE IN ANALYTICAL DETECTION
DE69628999D1 (en) ATP eliminator and method for determining biological cells
DE69819332D1 (en) IMPROVED ANTIBODIES AGAINST IgE AND METHOD FOR IMPROVING ANTIBODIES
ATE351910T1 (en) COMPOSITIONS AND METHODS CONTAINING OB-FUSION PROTEIN
DE69534399D1 (en) Method and device for determining feature points
DE69839778D1 (en) RESISTANCE AND METHOD FOR ITS MANUFACTURE
DE69707325D1 (en) Imaging material and method
DE69732225D1 (en) Process for the encapsulation of biologically active substances in erythrocytes and apparatus therefor
DE69700253D1 (en) Method and device for determining the concentration of an ingredient
EP0981640A4 (en) METHOD FOR DETERMINING THE TARGETED EFFECT OF MEDICAMENTS
DE69940321D1 (en) COMPOSITION AND METHOD FOR IDENTIFYING RETICULATED CELLS
DE60044694D1 (en) Method for the determination of cholesterol and sensor therefor
DE69739854D1 (en) SYSTEM AND METHOD FOR DETERMINING VOLTAGES
DE69828571D1 (en) Blood filter set and associated method for obtaining blood components
DE69812232D1 (en) Coating composition and coating method
DE69932427D1 (en) METHOD AND TESTS USEFUL IN THE TREATMENT OF ALCOHOL DEPENDENCY OR ABUSE
DE69822830D1 (en) METHOD AND DEVICE FOR DETERMINING AND CHARACTERIZING PARTICLES
EP1012334A4 (en) COMPOSITIONS AND METHODS FOR DETERMINING ANTI-VIRAL ACTIVE SUBSTANCE SUSCEPTIBILITY AND RESISTANCE AND ANTI-VIRAL ACTIVE SUBSTANCE SCREENING
DE69330077D1 (en) TEST SET AND METHOD FOR DETERMINING PESTICIDES
DE69822918D1 (en) Electronic part and process for its manufacture
DE69730268D1 (en) Method and system for determining amounts of colorant
EP0781142A4 (en) COMPOSITIONS AND METHOD FOR PROVIDING POLYPEPTIDES
DE50015719D1 (en) ELECTROCHEMICAL GAS SENSOR AND METHOD FOR DETERMINING GAS COMPONENTS
EP0975801A4 (en) METHOD FOR THE EXAMINATION OF ANTIMICROBIAL ACTIVE SUBSTANCES WITH AARC AND COMPOSITIONS THEREOF

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PARKIN, NEIL, T.

Inventor name: WHITCOMB, JEANNETTE, M.

Inventor name: CAPON, DANIEL, J.

A4 Supplementary search report drawn up and despatched

Effective date: 20041111

17Q First examination report despatched

Effective date: 20050622

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MONOGRAM BIOSCIENCES, INC.

17Q First examination report despatched

Effective date: 20050622

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1025362

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090324